Cardiac transthyretin/leukocyte chemotactic factor (LECT) 2 double amyloidosis in a patient suffering from heart failure
- PMID: 35925392
- DOI: 10.1007/s00392-022-02045-8
Cardiac transthyretin/leukocyte chemotactic factor (LECT) 2 double amyloidosis in a patient suffering from heart failure
Similar articles
-
Transthyretin amyloid cardiomyopathy.Med Clin (Barc). 2021 Feb 12;156(3):126-134. doi: 10.1016/j.medcli.2020.06.064. Epub 2020 Oct 31. Med Clin (Barc). 2021. PMID: 33138983 Review. English, Spanish.
-
Amyloid transthyretin cardiac amyloidosis with different manifestations, test findings and types.BMJ Case Rep. 2023 Apr 20;16(4):e250972. doi: 10.1136/bcr-2022-250972. BMJ Case Rep. 2023. PMID: 37080632 Free PMC article.
-
Understanding Changes in Functional Capacity After TTR Stabilization in Patients With Transthyretin Cardiac Amyloidosis.Circ Heart Fail. 2022 Jul;15(7):e009387. doi: 10.1161/CIRCHEARTFAILURE.122.009387. Epub 2022 Jun 29. Circ Heart Fail. 2022. PMID: 35766044 No abstract available.
-
Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.Annu Rev Med. 2020 Jan 27;71:203-219. doi: 10.1146/annurev-med-052918-020140. Annu Rev Med. 2020. PMID: 31986086 Review.
-
Machine Learning Identifies Plasma Metabolites Associated With Heart Failure in Underrepresented Populations With the TTR V122I Variant.J Am Heart Assoc. 2023 Apr 18;12(8):e027736. doi: 10.1161/JAHA.122.027736. Epub 2023 Apr 12. J Am Heart Assoc. 2023. PMID: 37042260 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials